Dongcheng Pharmaceutical: Yunkang Pharmaceutical's Yttrium-90 Radionuclide Has Carried Out Customized Production
Dongcheng Pharmaceutical's subsidiary, Yunké Pharmaceutical, has begun customized production of Yttrium-90 radioisotopes. While this marks a new production capability, the current revenue generated from this specific product is relatively small. The company's statement indicates a nascent stage for this particular venture. AI